Dr. Daniel Keesman

Dr. Daniel Keesman has extensive experience in various leadership roles. Dr. Daniel served as the Chief Executive Officer of August Faller GmbH & Co. KG, where they were responsible for strategic developments, business activities, operational functions, international sites, and financial results. Dr. Daniel successfully acquired and integrated a packaging company in Copenhagen and invested in a greenfield packaging plant in Lodz.

Dr. Keesman also served as a Member of the Board of Directors at LasX Industries. Additionally, they worked as an Independent Consultant at DK Business Consulting and as the CEO at Genedata. Prior to that, they held the position of Co-CEO at LION bioscience and Vice President Europe at Elsevier MDL. In their role at Elsevier MDL, they were responsible for managing software businesses and operations in multiple locations, increasing the company's position as a market leader, and integrating several companies into one operational organization for Europe.

Dr. Daniel Keesman completed their education in the field of Chemistry with a focus on Inorganic Chemistry. From 1982 to 1992, they attended the University of Stuttgart, where they earned their degree of Dr. rer. nat. During their studies, from 1986 to 1987, they also spent some time at Heidelberg University, although the specific degree obtained during that period is unknown.